272 related articles for article (PubMed ID: 8485271)
1. Cisapride in the treatment of gastro-oesophageal reflux disease.
Robertson CS; Evans DF; Ledingham SJ; Atkinson M
Aliment Pharmacol Ther; 1993 Apr; 7(2):181-90. PubMed ID: 8485271
[TBL] [Abstract][Full Text] [Related]
2. Cisapride for gastro-oesophageal reflux and peptic oesophagitis.
Cucchiara S; Staiano A; Capozzi C; Di Lorenzo C; Boccieri A; Auricchio S
Arch Dis Child; 1987 May; 62(5):454-7. PubMed ID: 3300570
[TBL] [Abstract][Full Text] [Related]
3. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of cisapride on symptoms and healing of gastro-oesophageal reflux disease: a review.
Richter JE
Scand J Gastroenterol Suppl; 1989; 165():19-27; discussion 27-8. PubMed ID: 2690321
[TBL] [Abstract][Full Text] [Related]
5. Effect of cisapride on nocturnal transient lower oesophageal sphincter relaxations and nocturnal gastro-oesophageal reflux in patients with oesophagitis: a double-blind, placebo-controlled study.
Pehlivanov N; Sarosiek I; Whitman R; Olyaee M; McCallum R
Aliment Pharmacol Ther; 2002 Apr; 16(4):743-7. PubMed ID: 11929392
[TBL] [Abstract][Full Text] [Related]
6. Influence of cisapride on food-stimulated gastro-oesophageal reflux: a radiological study.
Gelineck J; Aksglade K; Funch-Jensen P; Thommesen P
Rontgenblatter; 1990 Aug; 43(8):352-4. PubMed ID: 2204995
[TBL] [Abstract][Full Text] [Related]
7. Cisapride: influence on oesophageal and gastric emptying and gastro-oesophageal reflux in patients with reflux oesophagitis.
Collins BJ; Spence RA; Ferguson R; Laird J; Love AH
Hepatogastroenterology; 1987 Jun; 34(3):113-6. PubMed ID: 3301606
[TBL] [Abstract][Full Text] [Related]
8. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease.
Cucchiara S; Staiano A; Boccieri A; De Stefano M; Capozzi C; Manzi G; Camerlingo F; Paone FM
Gut; 1990 Jan; 31(1):21-5. PubMed ID: 2180792
[TBL] [Abstract][Full Text] [Related]
9. Maintenance therapy with cisapride after healing of erosive oesophagitis: a double-blind placebo-controlled trial.
McDougall NI; Watson RG; Collins JS; McFarland RJ; Love AH
Aliment Pharmacol Ther; 1997 Jun; 11(3):487-95. PubMed ID: 9218071
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of cisapride and ranitidine at controlling oesophageal acid exposure in erosive oesophagitis.
Pouderoux P; Kahrilas PJ
Aliment Pharmacol Ther; 1995 Dec; 9(6):661-6. PubMed ID: 8824654
[TBL] [Abstract][Full Text] [Related]
11. The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients.
Van Herwaarden MA; Samsom M; Van Nispen CH; Verlinden M; Smout AJ
Aliment Pharmacol Ther; 2000 Apr; 14(4):453-62. PubMed ID: 10759625
[TBL] [Abstract][Full Text] [Related]
12. The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease.
Hatlebakk JG; Johnsson F; Vilien M; Carling L; Wetterhus S; Thøgersen T
Scand J Gastroenterol; 1997 Nov; 32(11):1100-6. PubMed ID: 9399390
[TBL] [Abstract][Full Text] [Related]
13. The effect of cisapride on oesophageal motility and lower sphincter function in patients with gastro-oesophageal reflux disease.
Finizia C; Lundell L; Cange L; Ruth M
Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):9-14. PubMed ID: 11782569
[TBL] [Abstract][Full Text] [Related]
14. Effect of cisapride on postprandial gastro-oesophageal reflux.
Holloway RH; Downton J; Mitchell B; Dent J
Gut; 1989 Sep; 30(9):1187-93. PubMed ID: 2680794
[TBL] [Abstract][Full Text] [Related]
15. [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride].
Carrasco Gandía S; Lama Moré R; Prieto Bozano G; Polanco Allue I
An Esp Pediatr; 1990 Jun; 32(6):485-8. PubMed ID: 2221622
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology and treatment of gastro-oesophageal reflux disease.
Vantrappen G; Janssens J
Scand J Gastroenterol Suppl; 1989; 165():7-12; discussion 27-8. PubMed ID: 2574907
[TBL] [Abstract][Full Text] [Related]
17. Healing of grade-II and III oesophagitis through motility stimulation with cisapride.
Lepoutre L; Van der Spek P; Vanderlinden I; Bollen J; Laukens P
Digestion; 1990; 45(2):109-14. PubMed ID: 2190850
[TBL] [Abstract][Full Text] [Related]
18. Cisapride in gastro-oesophageal reflux disease: effects on oesophageal motility and intra-oesophageal pH.
Wienbeck M; Li Q
Scand J Gastroenterol Suppl; 1989; 165():13-8; discussion 27-8. PubMed ID: 2690320
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of gastro-oesophageal reflux in cystic fibrosis.
Cucchiara S; Santamaria F; Andreotti MR; Minella R; Ercolini P; Oggero V; de Ritis G
Arch Dis Child; 1991 May; 66(5):617-22. PubMed ID: 2039253
[TBL] [Abstract][Full Text] [Related]
20. Cisapride in pediatric gastroesophageal reflux.
Scott RB; Ferreira C; Smith L; Jones AB; Machida H; Lohoues MJ; Roy CC
J Pediatr Gastroenterol Nutr; 1997 Nov; 25(5):499-506. PubMed ID: 9360203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
